Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Sanofi and Regeneron Pharmaceuticals are expanding their immunology alliance, adding four next-generation antibody programs. Regeneron will receive $1 billion upfront and up to $7 billion in potential milestone payments.
Regeneron and Sanofi have expanded their antibody alliance to co-develop four long-acting immunology antibodies. Regeneron will receive a $1 billion upfront payment and up to $7 billion in potential milestones, with costs and profits to be shared 50:50 globally.
On Monday, AstraZeneca (NASDAQ: AZN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary AstraZeneca reported a 6% growth in total revenue for the fi